Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
editas medicine
3
×
life sciences
national blog main
biotech
boston
crispr
crispr therapeutics
crispr-cas9
gene editing
intellia therapeutics
national top stories
san francisco blog main
san francisco top stories
agios therapeutics
allergan
base editing
branden moriarty
broad institute
cancer
cas13
clinical trials
cynthia collins
david liu
dna
drugs
editas
editor
editr
enzyme
feng zhang
harvard university
john evans
katrine bosley
keith joung
leber congenital amaurosis
massachusetts general hospital
national
nicole gaudelli
What
crispr
editing
3
×
gene
medicine
3
×
cas
editas
allergan
beam
blessing
bosley
cancer
cells
ceo
check
clinical
cusp
defect
depart
drive
edited
editor
experimental
fears
flag
founders
genetic
gotten
guardian
harvard
human
humans
jump
katrine
known
lab
malfunction
mass
million
nature
new
Language
Current search:
editing
×
medicine
×
" editas medicine "
×
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@xconomy.com
5 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M